InMode (NASDAQ:INMD) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

InMode Ltd. (NASDAQ:INMD) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.17 and traded as high as $15.36. InMode shares last traded at $15.28, with a volume of 516,721 shares.

Wall Street Analysts Forecast Growth

INMD has been the topic of a number of analyst reports. Barclays set a $19.00 price target on InMode and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Robert W. Baird lowered their price objective on InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.00.

InMode Trading Down 0.8%

The company has a market capitalization of $889.22 million, a PE ratio of 11.38 and a beta of 1.91. The business’s fifty day moving average is $14.09 and its two-hundred day moving average is $14.18.

InMode (NASDAQ:INMD) last issued its earnings results on Wednesday, May 6th. The healthcare company reported $0.25 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.05). InMode had a net margin of 23.27% and a return on equity of 13.47%. The business had revenue of $82.02 million for the quarter, compared to analysts’ expectations of $79.84 million. During the same quarter in the prior year, the business posted $0.31 earnings per share. The business’s revenue for the quarter was up 5.3% on a year-over-year basis.

Hedge Funds Weigh In On InMode

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Leonteq Securities AG purchased a new stake in shares of InMode during the 4th quarter valued at about $26,000. Quadrant Capital Group LLC raised its holdings in shares of InMode by 127.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after purchasing an additional 1,091 shares during the last quarter. Advisory Services Network LLC purchased a new position in shares of InMode during the third quarter valued at approximately $37,000. Basepoint Wealth LLC bought a new position in InMode during the fourth quarter valued at approximately $39,000. Finally, Deutsche Bank AG lifted its position in InMode by 35.9% during the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after purchasing an additional 1,037 shares during the period. Institutional investors own 68.04% of the company’s stock.

InMode Company Profile

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.